Hello, Fool! | Login | Signup | My Fool
Oct 13, 2008 6:33 PM ET | Feedback | Site Changes | Help
The Company discovers, develops, manufactures and markets prescription pharmaceuticals for important areas of healthcare: cancer, cardiovascular, gastrointestinal, infection, neuroscience, and respiratory and inflammation.
View All Commentary (AZN)
Recs
btarabishy (< 20) Submitted: 12/20/06 3:26 PM : Start Price: $49.82 AZN Score: 16.19
Unfairly undervalued compared to its peers. Blockbuster portfolio and heading in the right directions in its pipelines. Expect the stock to recover with strong sales in 07.
Report this Post Replies: 0 | Reply
Oops! There appears to be a problem with your comment. Check to see if there's something you left out.
Terms & Conditions
RSS Headlines
Fool UK